About this trial
The investigators hypothesize that infertility patients undergoing IUI who receive female autologous platelet-rich plasma (PRP) co-incubation with husband's sperm would have higher clinical pregnancy rate.
Primary outcome:
To compare the incidence of clinical pregnancy outcome in those infertility patients undergoing IUI with female PRP co-incubation with husband's sperm group and non-PRP group.
Secondary outcomes:
* To evaluate the post-culture sperm parameters between the intervention group and control group * To evaluate the IUI parameter between the intervention group and control group * To evaluate the safeness between the female PRP co-incubation with husband's sperm in the IUI group and non-PRP group, including potential infection rate or other pregnancy outcomes such as miscarriage, multiple pregnancy, ectopic pregnancy and molar pregnancy
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who were eligible for IUI cycles in Assissted Reproduction Technolog unit, Prince of Wales Hospital
Female patients aged >18 years old and < 42 years old
BMI < 30 kg/m2
Disqualifiers
Concurrent administration of other agents such as prednisolone, intravenous immunoglobulin, or G-CSF
Administration of anticoagulants or NSAIDs at least 7 days before PRP infuse
Drug addiction
Untreated urinary tract infection
Trial design
Parallel
Treatments tested in this trial
non-PRP group (control group)
Other interventionnon-PRP group (control group): non-PRP in the conventional IUI
PRP group (intervention group)
Other interventionPRP group (intervention group): female PRP co-incubation with husband's sperm in the IUI
Treatment groups
Trial outcomes
Primary outcomes
Clinical pregnancy
To determine the rate of clinical pregnancy outcome in subjects undergoing IUI with PRP co-incubation with husband's sperm group than non-PRP group.
Secondary outcomes
Sperm motility
To evaluate the Sperm motility between the intervention group and control group
beta hCG positivity
To evaluate the rate of beta hCG positivity between the intervention group and control group
Infection or other complications
To evaluate the rate of potential infection in the intervention group and control group
Miscarriage
To determine to the rate miscarriage outcome in the intervention group and control group
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: